Why Janus Henderson Investors for active equity investing?
Janus Henderson’s global active equity platform delivers high-conviction strategies designed to help clients achieve long-term growth and risk-adjusted returns.
Our experienced investment professionals leverage deep fundamental research and global insights to build equity solutions that aim to outperform benchmarks..
Our equity platform
Active platform, global reach
Active platform, global reach
A truly global, actively managed equity platform, investing with high-conviction across all regions and styles.
Focused investment expertise
Focused investment expertise
Our experienced equity specialists drive high-conviction, research-driven strategies. Their focused expertise allows for agile decision-making.
A history of delivering performance for clients
A history of delivering performance for clients
As a pure active asset manager, our mission is to deliver long-term, risk-adjusted returns that exceed benchmarks and peer averages.
Our track record speaks
Institutional-grade equity solutions
Active equity solutions powered by deep research, global expertise, and tailored portfolio design to help institutions achieve long-term, risk-adjusted returns
£188.8bn
Equity AUM
148
Equities investment professionals
19
Average years' experience
As at 30 September 2025
Invest in a brighter future today today
Investment heads Marc Pinto, CFA and Lucas Klein discuss the Janus Henderson difference: where world-class investment talent meets a commitment to your financial goals.
Hear them outline how our disciplined approach to equities, focused on rigorous stock selection and risk management, is driven by an unwavering dedication to active investing.
Equities Strategies
We offer actively managed equity portfolios spanning sectors, geographies, and market caps.
Name
About this product
For investors targeting positive returns in all market conditions from a long/short equity strategy with typically low sensitivity to markets..
A biotechnology strategy that seeks to leverage a disciplined approach to identify compelling opportunities across the biotech landscape in both public and private investments.
By understanding the science and business of health care, our experienced team seeks to invest in companies addressing unmet medical needs or improving efficiencies.
By focusing on companies that contribute to the development of a more sustainable global economy, our low-carbon investment approach aims to deliver compounding growth and attractive investment returns.
Invests in small companies listed globally, seeking long-term capital growth by identifying good quality but potentially undervalued stocks.
A global approach to investing in technology companies from a highly experienced team.
Insights delivered to your inbox
Receive timely perspectives on the themes shaping today’s investment landscape.